BD’s R&D Pipeline Includes Micro-Needle Drug Delivery; Q4 Sales Up 8%
This article was originally published in The Gray Sheet
Executive Summary
BD is preparing for functionality testing of its development-stage Micro Infuser wearable drug-delivery system, incorporating micro-needles to deliver drugs just below the skin's surface to minimize pain